seed
Stage
About
Amber is a biotechnology company developing an RNA editing platform that enables large, precise edits to RNA without altering DNA, aiming to treat complex genetic diseases with a single therapeutic product.
Explore Amber's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.